Home > Category > Signaling Pathways > Immunology & Inflammation > PD-1/PD-L1 > Pidilizumab (Anti-PDCD1 / PD-1 / CD279)

Pidilizumab (Anti-PDCD1 / PD-1 / CD279)

ChemLeader 95+%

Catalog No：CLA1320 CAS No.：1036730-42-3 MDLNo： Formula： MW：

Collect Share

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
1 mg	3-5days	$800.00	Visible after login	- +
5 mg	3-5days	$2300.00	Visible after login	- +
10 mg	3-5days	$4200.00	Visible after login	- +
50 mg	3-5days	$18500.00	Visible after login	- +
100 mg	3-5days	$34000.00	Visible after login	- +

Chemical safety data sheet(MSDS)

Download MSDS

Inquiry Add To Cart

Product Overview
Related documents
Product details
Related literature

Product Overview

Product Name	Pidilizumab (Anti-PDCD1 / PD-1 / CD279)
CAS	1036730-42-3

Product details

Pidilizumab (Anti-PDCD1 / PD-1 / CD279) is a humanized monoclonal antibody targeting human PD-1 (programmed cell death 1; PDCD1). It has immunomodulating and antitumor activities and can be used in treatment of metastatic melanoma. MW :144.48 KD.

Related literature

Sorry, there is no relevant literature

Sorry, no related items

History

CLA1320

Pidilizumab (Anti-PDCD1 / PD-1 / CD279)

1036730-42-3 95+%